Isabelle Dimier-Poisson Selected Research

Isabelle Dimier-Poisson Research Topics

Disease

15	Toxoplasmosis 01/2022 - 03/2006
8	Infections 01/2021 - 07/2004
7	Congenital Toxoplasmosis 07/2021 - 10/2006
5	Neoplasms (Cancer) 01/2022 - 08/2009
3	Ileitis 01/2020 - 08/2010
3	Inflammation (Inflammations) 01/2019 - 08/2010
2	Cysts 01/2019 - 02/2017
2	Parasitic Diseases (Parasitic Disease) 11/2011 - 11/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Lice Infestations (Pediculosis) 01/2021
1	Thymoma (Thymic Carcinoma) 11/2020
1	Babesiosis (Piroplasmosis) 12/2019
1	Necrosis 01/2019
1	Breast Neoplasms (Breast Cancer) 11/2018
1	Hepatitis B 04/2013
1	Scorpion Stings 04/2012
1	Communicable Diseases (Infectious Diseases) 08/2009

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 01/2022 - 10/2006
8	AntigensIBA 01/2022 - 07/2004
4	CytokinesIBA 12/2020 - 01/2019
2	pyridazineIBA 07/2021 - 01/2018
2	calcium-dependent protein kinaseIBA 07/2021 - 01/2018
2	SaltsIBA 07/2021 - 01/2018
2	SP230IBA 07/2021 - 01/2018
2	AntibodiesIBA 01/2021 - 02/2017
2	Biological ProductsIBA 01/2021 - 11/2020
2	Neutralizing AntibodiesIBA 01/2021 - 01/2019
2	InterferonsIBA 11/2020 - 08/2010
2	Interleukin-22 (IL-22)IBA 01/2020 - 01/2019
2	Immunoglobulin G (IgG)IBA 11/2018 - 02/2017
2	Interleukin-10 (Interleukin 10)IBA 02/2017 - 08/2010
2	A-Form DNA (A-DNA)IBA 02/2017 - 11/2011
2	Recombinant ProteinsIBA 02/2017 - 11/2011
1	Therapeutic UsesIBA 01/2022
1	monophosphoryl lipid AIBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	LigandsIBA 01/2022
1	Pharmaceutical PreparationsIBA 07/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Immunoglobulin FragmentsIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	lotilanerIBA 01/2021
1	Single-Chain AntibodiesIBA 01/2021
1	Ivermectin (Mectizan)FDA Link 01/2021
1	talimogene laherparepvecIBA 11/2020
1	Interleukin-33IBA 01/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 11/2018
1	maleimideIBA 11/2018
1	PyridazinesIBA 01/2018
1	Interleukin-2 (IL2)IBA 02/2017
1	Immunoglobulin A (IgA)IBA 02/2017
1	Phosphotransferases (Kinase)IBA 02/2017
1	Poly I-CIBA 02/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2017
1	Cholera ToxinIBA 02/2017
1	Interleukin-5 (Interleukin 5)IBA 02/2017
1	Subunit VaccinesIBA 02/2017
1	Virulence Factors (Pathogenicity Factors)IBA 02/2017
1	Monatide (IMS 3015)IBA 02/2017
1	NanovaccinesIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Protein SIBA 04/2013
1	Interleukin-1 (Interleukin 1)IBA 01/2013
1	VenomsIBA 04/2012
1	Antivenins (Antivenoms)IBA 04/2012
1	Monoclonal AntibodiesIBA 03/2012
1	Interleukin-17 ReceptorsIBA 08/2010
1	Interleukin-17 (Interleukin 17)IBA 08/2010
1	InterleukinsIBA 08/2010
1	DNA VaccinesIBA 05/2009
1	Nucleic AcidsIBA 11/2007
1	RNA (Ribonucleic Acid)IBA 03/2006

Therapy/Procedure

2	Therapeutics 01/2022 - 11/2020
1	Transplantation 01/2022
1	Immunotherapy 11/2020
1	Subcutaneous Injections 11/2020
1	Drug Therapy (Chemotherapy) 11/2018
1	Intraperitoneal Injections 09/2015
1	Injections 03/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2009